RT Journal Article
SR Electronic
T1 THE EMOTIONAL IMPACT OF THE ASRM GUIDELINES ON FERTILITY PATIENTS DURING THE COVID-19 PANDEMIC
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.29.20046631
DO 10.1101/2020.03.29.20046631
A1 Jenna Turocy
A1 Alex Robles
A1 Daniel Hercz
A1 Mary D’Alton
A1 Eric J. Forman
A1 Zev Williams
YR 2020
UL http://medrxiv.org/content/early/2020/04/07/2020.03.29.20046631.abstract
AB Objective To survey fertility patients’ agreement with ASRM recommendations during the COVID-19 pandemic and the emotional impact on them.Design An online survey was sent to current fertility patientsSetting New York City academic fertility practice at the epicenter of the COVID-19 pandemicPatient(s) Fertility patients seen within the last yearIntervention(s) NoneMain Outcome Measures(s) Patient agreement with the ASRM recommendations during the COVID-19 pandemic and the emotional impact rated on a Likert scale.Result(s) A total of 518 patients completed the survey for a response rate of 17%. Fifty percent of respondents had a cycle canceled due to the COVID-19 pandemic. Of those who had a cycle cancelled, 85% of respondents found it to be moderately to extremely upsetting with 22% rating it to be equivalent to the loss of a child. There was no difference on the emotional impact based on the type of cycle cancelled. Fifty-five percent of patients agreed that diagnostic procedures such as hysterosalpingograms should be cancelled while 36% of patients agreed all fertility cycles should be cancelled. Patients were slightly more likely to agree with the ASRM guidelines if they have an upcoming cycle cancelled (p = 0.041). Of all respondents 82% would have preferred to have the option to start a treatment cycle in consultation with their doctor.Conclusion(s) Given the severity of the COVID-19 pandemic, the physical, financial and emotional impact of this unprecedented threat cannot be underestimated in our fertility patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/A. No funding required.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be made available upon request